Cyberonics Reports Consistently Positive Results From The E-36 And E-37 Studies For VNS Therapy Delivered By AspireSR(R) Generator

New Results Presented at the 68th American Epilepsy Society (AES) Annual Meeting HOUSTON, Dec. 8, 2014 -- (Healthcare Sales & Marketing Network) -- Cyberonics, Inc. (CYBX), maker of the VNS Therapy® System implanted in more than 80,000 patients, an... Devices, NeurologyCyberonics, AspireSR, VNS Therapy System
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news